Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Antiandrogens don't help with COVID-19 and aren't recommended.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

iPSCs are promising for studying and treating COVID-19.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

New vaccine technologies are improving global health by making vaccines more effective and long-lasting.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Post-COVID conditions increase health care needs for six months after infection.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.